#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bone marrow disorder Germ cell cancer Arterial disorder Adenocarcinoma pancreas B-cell small lymphocytic lymphoma refractory Fibrosarcoma metastatic Liposarcoma recurrent Glioma Pneumonia Adenomatous polyposis coli Philadelphia positive chronic myeloid leukaemia Hepato-lenticular degeneration Angiosarcoma Renal disorder Congenital pseudarthrosis More trials…

    Learn about Rare Diseases

    Andersen-Tawil syndrome Cystic fibrosis – Basic Information Noonan syndrome – Diagnostics Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Acquired haemophilia – Basic Information Thrombotic thrombocytopenic purpura Prolymphocytic leukaemia – Treatment Alexander disease – Trials in Disease Langerhans’ cell histiocytosis – Life with Disease Nephrotic syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Alfacalcidol Placebo GSKVX000000070248 Hct116-B YOHIMBINE HYDROCHLORIDE Betamethasone Sodium Phosphate GS-248 Zinc Oxide Ranolazine MRNA-1345 [18F]-Altanserin Garetosmab Pemetrexed Diacid Monohydrate Triptorelin Tinlarebant Asundexian RIMIDUCID Obeticholic Acid BUDOPRUTUG Anhydrous Caffeine More therapies…

    Learn about Your Condition

    Renal transplant CDKL5 deficiency disorder Glanzmann's disease Cirrhosis alcoholic Bone marrow disorder Malignant glioma Breast proliferative changes Burkitt's lymphoma Bacterial prostatitis Anaplastic thyroid cancer Rhabdoid tumour Deafness neurosensory Bile duct cancer Adrenal insufficiency Hyperglycaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effectiveness of NANOULCOR for Patients with Severe Corneal Ulcers Using Allogenic Limbal Cells and Keratocytes

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Allogenic Corneal-Derived Adult Keratocytes, Ex-Vivo Expanded
    • Allogenic Sclerocorneal Limbus Stem-Derived Adult Limbal Cells, Ex-Vivo Expanded
    Spain

  • Study on Psilocybin and Apomorphine for Improving Consciousness in Patients with Coma and Brain Injury

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Coma
    Investigated Drugs:
    • Apomorphine Hydrochloride Hemihydrate
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    • Sodium Chloride
    Denmark

  • Study on the Safety and Feasibility of Using Autologous Oral Mucosa-Derived Keratinocytes and Fibroblasts for Treating Cleft Palate Patients

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Autologous Oral Mucosa-Derived Adult Fibroblasts, Ex-Vivo Expanded
    • Autologous Oral Mucosa-Derived Adult Keratinocytes, Ex-Vivo Expanded
    Spain

  • Study on Long-Term Safety of Tolebrutinib for Patients with Relapsing or Progressive Multiple Sclerosis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Progressive relapsing multiple sclerosis
    • Secondary progressive multiple sclerosis
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Anhydrous Cholestyramine
    • Magnetic Resonance Imaging Contrast Media
    • Teriflunomide
    Denmark The Netherlands

  • Study on the Effectiveness and Safety of AV-EC2023 Tablets for Adults with Insomnia

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Insomnia
    Investigated Drugs:
    • Av-Ec2023
    Germany

  • Study Comparing Lidocaine Gel and Tetracaine/Oxybuprocaine Eye Drops for Anesthesia in Glaucoma Patients Undergoing Needling Procedures

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Glaucoma
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Oxybuprocaine Hydrochloride
    • Tetracaine Hydrochloride
    Spain
Previous Page
1 … 884 885 886 887 888 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!